Literature DB >> 29929036

Evaluation of common housekeeping proteins under ischemic conditions and/or rt-PA treatment in bEnd.3 cells.

Pau Comajoan1, Carme Gubern1, Gemma Huguet1, Joaquín Serena1, Elisabet Kádár2, Mar Castellanos3.   

Abstract

Thrombolysis with recombinant tissue plasminogen activator (rt-PA) is the only pharmacological approved treatment for ischemic stroke, despite its associated increasing risk of hemorrhagic transformation. Since many of rt-PA effects in blood-brain barrier (BBB) are not well characterized, the study of protein changes in BBB cells after rt-PA administration may help to understand its adverse effects. Our aim was to analyze protein levels of four commonly used housekeeping proteins: β-Actin, α-Tubulin, GAPDH and HPRT in bEnd.3 endothelial cell line subjected to oxygen and glucose deprivation (OGD) conditions and rt-PA treatment to determine their reliability as Western blot loading controls. bEnd.3 monolayers were subjected to 2.5 h of OGD and reperfusion with/without 20 μg/ml of rt-PA. At 3, 6, 24 and 72 h post-OGD, protein levels were analyzed by Western blot using Stain-Free technology. OGD significantly decreased β-Actin, α-Tubulin, GAPDH and HPRT protein levels at 3, 6, 24 and 72 h post-OGD without significant rt-PA treatment effects except for the GAPDH levels increase in control condition at 3 h post-OGD. The present study clearly demonstrated that β-Actin, α-Tubulin, GAPDH and HPRT proteins are not suitable as loading controls for Western Blot analysis in bEnd.3 cells after OGD. SIGNIFICANCE: We reported altered levels of β-Actin, α-Tubulin, GAPDH and HPRT housekeeping proteins in bEnd.3 endothelial cell line after an ischemic insult. Therefore, we demonstrated that these proteins are not suitable as loading controls for Western Blot analysis in our experimental conditions and we recommended the use of Stain-Free gels as an alternative to traditional housekeeping proteins normalization.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood brain barrier; Endothelial cells; Housekeeping proteins; Ischemic stroke; OGD; rt-PA

Mesh:

Substances:

Year:  2018        PMID: 29929036     DOI: 10.1016/j.jprot.2018.06.011

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  6 in total

Review 1.  β-Actin: An Emerging Biomarker in Ischemic Stroke.

Authors:  Jiaqian Li; Fangyu Dai; Xuelian Kou; Bin Wu; Jie Xu; Songbin He
Journal:  Cell Mol Neurobiol       Date:  2022-05-13       Impact factor: 5.046

Review 2.  In Vitro Oxygen Glucose Deprivation Model of Ischemic Stroke: A Proteomics-Driven Systems Biological Perspective.

Authors:  Manju Babu; Nikhil Singh; Arnab Datta
Journal:  Mol Neurobiol       Date:  2022-01-26       Impact factor: 5.590

3.  The In Vitro Inhibitory Effect of Sivelestat on Elastase Induced Collagen and Metallopeptidase Expression in Equine Endometrium.

Authors:  Ana Amaral; Carina Fernandes; Maria Rosa Rebordão; Anna Szóstek-Mioduchowska; Karolina Lukasik; Barbara Gawronska-Kozak; Luís Telo da Gama; Dariusz J Skarzynski; Graça Ferreira-Dias
Journal:  Animals (Basel)       Date:  2020-05-16       Impact factor: 2.752

4.  Apremilast exerts protective effects on stroke outcomes and blood-brain barrier (BBB) dysfunction through regulating Rho-associated protein kinase 2 expression.

Authors:  Mingyuan Wang; Xiangyuan Meng; Zhihua Cheng
Journal:  Brain Behav       Date:  2022-08-15       Impact factor: 3.405

Review 5.  Glyceraldehyde-3-phosphate Dehydrogenase is a Multifaceted Therapeutic Target.

Authors:  Vladimir F Lazarev; Irina V Guzhova; Boris A Margulis
Journal:  Pharmaceutics       Date:  2020-05-02       Impact factor: 6.321

6.  Dragon's Blood Regulates Rac1-WAVE2-Arp2/3 Signaling Pathway to Protect Rat Intestinal Epithelial Barrier Dysfunction Induced by Simulated Microgravity.

Authors:  Yujuan Li; Shan Liu; Huayan Liu; Yaoyuan Cui; Yulin Deng
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.